" class="no-js "lang="en-US"> Global Access Diagnostics (GADx) - Medtech Alert
Thursday, March 28, 2024
Global Access Diagnostics (GADx) | Pharmtech Focus

Global Access Diagnostics (GADx)

About Global Access Diagnostics (GADx)

Global Access Diagnostics (GADx)

Global Access Diagnostics (GADx) is your proven partner, from concept to manufacturing, for rapid diagnostic solutions. We develop innovative, quality, custom rapid tests – from antibody and protein development to production. In addition to having our own robust product portfolio to solve pressing health needs, we also offer flexible volume contract manufacturing services. And we are the world’s first full-suite social enterprise diagnostics company, re-investing 100% of our profits to increase access to diagnostics for people who need them the most.

Related Story

COVID-19 Rapid Antigen Self-Test, COVI-Go, receives FDA Emergency Use Authorization for Home Use

February 24 2023

Mologic, the US subsidiary of Global Access Diagnostics (GADx), a leading developer of lateral flow […]

Global Access Diagnostics (GADx) Formed to Expand Affordable Access to Advanced Rapid Diagnostic Technologies

June 16 2022

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global […]